Elicera Therapeutics (Sweden) Buy Hold or Sell Recommendation
| ELIC Stock | 1.89 0.15 8.62% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Elicera Therapeutics AB is 'Strong Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Elicera Therapeutics AB given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Elicera Therapeutics AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Elicera Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Elicera and provide practical buy, sell, or hold advice based on investors' constraints. Elicera Therapeutics AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Elicera |
Execute Elicera Therapeutics Buy or Sell Advice
The Elicera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Elicera Therapeutics AB. Macroaxis does not own or have any residual interests in Elicera Therapeutics AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Elicera Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | OK | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Elicera Therapeutics Trading Alerts and Improvement Suggestions
| Elicera Therapeutics may become a speculative penny stock | |
| Elicera Therapeutics had very high historical volatility over the last 90 days | |
| Elicera Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 587. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 587. | |
| Elicera Therapeutics generates negative cash flow from operations | |
| About 63.0% of the company shares are held by company insiders |
Elicera Therapeutics Returns Distribution Density
The distribution of Elicera Therapeutics' historical returns is an attempt to chart the uncertainty of Elicera Therapeutics' future price movements. The chart of the probability distribution of Elicera Therapeutics daily returns describes the distribution of returns around its average expected value. We use Elicera Therapeutics AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Elicera Therapeutics returns is essential to provide solid investment advice for Elicera Therapeutics.
| Mean Return | 0.45 | Value At Risk | -5.58 | Potential Upside | 10.32 | Standard Deviation | 4.60 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Elicera Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Elicera Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Elicera Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Elicera Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Elicera stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.45 | |
β | Beta against Dow Jones | -0.91 | |
σ | Overall volatility | 4.61 | |
Ir | Information ratio | 0.09 |
Elicera Therapeutics Volatility Alert
Elicera Therapeutics AB shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Elicera Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Elicera Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Elicera Therapeutics Fundamentals Vs Peers
Comparing Elicera Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Elicera Therapeutics' direct or indirect competition across all of the common fundamentals between Elicera Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Elicera Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Elicera Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Elicera Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Elicera Therapeutics to competition |
| Fundamentals | Elicera Therapeutics | Peer Average |
| Return On Equity | -0.39 | -0.31 |
| Return On Asset | -0.23 | -0.14 |
| Operating Margin | (23.30) % | (5.51) % |
| Current Valuation | 42.8 M | 16.62 B |
| Shares Outstanding | 19.78 M | 571.82 M |
| Shares Owned By Insiders | 62.87 % | 10.09 % |
| Price To Book | 2.21 X | 9.51 X |
| Price To Sales | 106.48 X | 11.42 X |
| Revenue | 587 | 9.43 B |
| Gross Profit | 587 | 27.38 B |
| EBITDA | (13.11 M) | 3.9 B |
| Net Income | (13.12 M) | 570.98 M |
| Book Value Per Share | 1.85 X | 1.93 K |
| Cash Flow From Operations | (14.29 M) | 971.22 M |
| Earnings Per Share | (0.86) X | 3.12 X |
| Number Of Employees | 1 | 18.84 K |
| Market Capitalization | 78.53 M | 19.03 B |
| Total Asset | 54.74 M | 29.47 B |
| Net Asset | 54.74 M |
Elicera Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Elicera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Elicera Therapeutics Buy or Sell Advice
When is the right time to buy or sell Elicera Therapeutics AB? Buying financial instruments such as Elicera Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Elicera Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Momentum Thematic Idea Now
Momentum
Large corporations operating in software, education, financial and car manufacturing industries. The Momentum theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Momentum Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Elicera Stock Analysis
When running Elicera Therapeutics' price analysis, check to measure Elicera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicera Therapeutics is operating at the current time. Most of Elicera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicera Therapeutics' price. Additionally, you may evaluate how the addition of Elicera Therapeutics to your portfolios can decrease your overall portfolio volatility.